Page 393 - Binder2

• Preventive
• Decentralized

…then our financial model must evolve accordingly.
Because if procedure-based revenue remains the
dominant paradigm, then therapies that reduce procedures
will always face systemic resistance—no matter how
effective or equitable they are.

Rebuilding Practice Around the Patient, Not the
Procedure

The promise of edible biologics is not just scientific—it’s
economic.

It offers a chance to reshape the incentives of care, so
that:

• Simplicity is rewarded, not penalized.
• Education and prevention are core services, not side
notes.
• And healing happens not because it’s billable—but
because it’s better.

This isn’t the end of specialty medicine. It’s the beginning
of specialty care that scales with compassion, not with
codes.

A New Kind of Training

Medical education hasn’t caught up to this revolution. Most
physicians are trained to:

391